News
News
PublISHED ON
UpDATED ON
Research funding available for next-generation biologics
The Swedish Research Council and Vinnova have formulated a national programme for protein research, method development and production of biologics. It is now possible to apply for up to 10 million SEK for protein research and process development for biologics. The call closes January 15, 2019.
The programme is a part of the government’s strategic investment in life science aiming to promote better health, face societal challenges, strengthen Sweden’s position as a leading country for research and development, and increase Sweden’s competitiveness in an international perspective.
The programme contains both protein research for biologics, as well as development of more efficient methods for next-generation production of biologics. The programme runs from 2016 to 2023 and comprises 320 million SEK in total.
A call for protein research and process development for biologics is now open and closes January 15, 2019.
You can find all the information (in Swedish) about the call on Vinnova’s website
External link..
MORE WITHIN THE SAME SUBJECT AREA
-
News |
Published 12 April 2022
Increased knowledge, national coordination and regular mappings of unclear areas and obstacles. This is the way forward for improving the utilisation of health data for research and innovation. We are now beginning the work of establishing national s...
-
News |
Published 6 April 2022
High quality and good opportunities to contribute to societal benefits summarise the applications approved within the research initiatives for post-COVID syndrome and follow-up studies of COVID-19 vaccines. In relation to studies of COVID-19 vaccines...
-
News |
Published 15 November 2021
The Swedish Research Council is allocating 50 million SEK to 14 research projects into post-COVID syndrome. The research shall contribute to developing knowledge within health and medical care, and improving diagnosis and therapy alternatives for pat...